Discussing Key Clinical Decisions in Managing Primary Biliary Cholangitis

Description

Therapy goals for primary biliary cholangitis (PBC) are increasingly individualized and aspire to rapidly achieve normalization of biochemical markers. At the same time, novel therapies are poised to change the PBC treatment landscape. Attend this interactive, case-based symposium to learn from expert faculty about novel emerging treatments that may offer patients improved outcomes in PBC. In addition, a patient advocate will join our faculty to relate her experience of living with PBC, the burden of symptoms and impact on quality of life, and how patients and clinicians can best work together to achieve treatment goals.

Supported by: Gilead Sciences, Inc. 
Organizer: Medscape Education

For more information and to register, visit: https://na.eventscloud.com/website/78519/